This is consistent with TRPM7’s documented induction role in the upregulation of CSCs markers such as CD133 and ALDH1, as well as promotes the proliferative, metastatic and CSCs-like phenotypes of GBM cells [17]. This evidence concerns the gene PROM1 and glioblastoma.